However, it should be noted that each disease also has its own specific risk loci (for example, NOD2 is mainly specific to CD, and PTPN22 is mainly specific to RA), indicating that the common genetic basis accounts for only part of the risk, with the remaining risk coming from disease-specific genetic factors (44). This evidence concerns the gene NOD2 and rheumatoid arthritis.